Charité - Universitätsmedizin Berlin
Steglitz, State of Berlin, 10249, Germany
NCT Number: NCT04871269
The aim of the current project is to investigate the impact of an activation of the cannabinoid system with an exogenous cannabinoid dronabinol (delta-9-tetrahydrocannabinol) on the formation of intrusive memories after analog trauma.
A well-established stress-film paradigm will be used to induce intrusive symptoms in healthy participants. In a double-blind placebo-controlled study, the impact of exogenous dronabinol on intrusive symptoms during exposure to a trauma film will be examined. The primary hypothesis is that exogenous oral dronabinol will decrease the number of intrusive memories recorded in the four days following experimental trauma compared with placebo controls.
This project will contribute to the current understanding of intrusive memory formation in PTSD and may guide the development of future pharmacological preventions.
This study is active but is not currently recruiting participants.
Notify Me18 year–45 year
Female
Interventional
Not applicable
Steglitz, State of Berlin, 10249, Germany
Recent data suggest that the cannabinoid-system is involved in stress regulation and posttraumatic stress disorder (PTSD) after traumatic events. In own of our own studies, we found reduced concentrations of the endocannabinoid arachidonylethanolamide (AEA) in BPD patients compared to healthy women (see Fig 1a). Furthermore, we found a correlation between hair concentrations of AEA and cortisol (p = .06; Fig 1b).
Low endocannabinoid signaling has been found in PTSD patients and might even present a precondition to develop PTSD after trauma. In consequence, increased endocannabinoid signaling during acquisition and consolidation of traumatic events might be a promising approach to prevent the development of PTSD. The aim of the current project is to investigate the impact of an activation of the cannabinoid system with an exogenous cannabinoid dronabinol (delta-9-tetrahydrocannabinol) on the formation of intrusive memories after analog trauma.
A well-established stress-film paradigm will be used to induce intrusive symptoms in healthy participants. In a double-blind placebo-controlled study, the impact of exogenous dronabinol on intrusive symptoms during exposure to a trauma film will be examined. The primary hypothesis is that exogenous oral dronabinol will decrease the number of intrusive memories recorded in the four days following experimental trauma compared with placebo controls.
This project will contribute to the current understanding of intrusive memory formation in PTSD and may guide the development of future pharmacological preventions.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dronabinol
Placebo
Time frame: four consecutive days
Influence of dronabinol on the development of intrusive memories measured with an intrusion diary
Time frame: Day 1
Influence of dronabinol on the noradrenergic system measured with salivary alpha-amylase
Time frame: Time Frame: Day 1
Influence of dronabinol on the HPA-axis measured with salivary cortisol
Time frame: Day 1
Influence of polygenic risk score on development of intrusive memories
Charite University, Berlin, Germany
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07419594
Intrusion, Intrusion Symptom
Berlin, State of Berlin, Germany
View Trial DetailsNCT06469333
Alterning Bilateral Stimulation, Consolidation/Recconsolidation Memory
Vandœuvre-lès-Nancy, France
View Trial DetailsNCT03012685
Intrusive Memories, Mental Disorders
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT03875391
Intrusive Memories, Mental Disorders
Berlin, Germany
View Trial Details